Blocking soluble guanylate cyclase could be the present and future of NO/cGMP inhibition for vasoplegia treatment. [Carta] (2018)
- Autor:
- Autor USP: EVORA, PAULO ROBERTO BARBOSA - FMRP
- Unidade: FMRP
- DOI: 10.1186/s13054-018-2024-y
- Assuntos: RESISTÊNCIA VASCULAR; CHOQUE SÉPTICO
- Idioma: Inglês
- Imprenta:
- Fonte:
- Título do periódico: Critical Care
- ISSN: 1364-8535
- Volume/Número/Paginação/Ano: v. 22, art. 104, 2018
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
EVORA, Paulo Roberto Barbosa. Blocking soluble guanylate cyclase could be the present and future of NO/cGMP inhibition for vasoplegia treatment. [Carta]. Critical Care. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1186/s13054-018-2024-y. Acesso em: 28 mar. 2024. , 2018 -
APA
Evora, P. R. B. (2018). Blocking soluble guanylate cyclase could be the present and future of NO/cGMP inhibition for vasoplegia treatment. [Carta]. Critical Care. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1186/s13054-018-2024-y -
NLM
Evora PRB. Blocking soluble guanylate cyclase could be the present and future of NO/cGMP inhibition for vasoplegia treatment. [Carta] [Internet]. Critical Care. 2018 ; 22[citado 2024 mar. 28 ] Available from: https://doi.org/10.1186/s13054-018-2024-y -
Vancouver
Evora PRB. Blocking soluble guanylate cyclase could be the present and future of NO/cGMP inhibition for vasoplegia treatment. [Carta] [Internet]. Critical Care. 2018 ; 22[citado 2024 mar. 28 ] Available from: https://doi.org/10.1186/s13054-018-2024-y - Possible advances in vasopressors and inotropes support in shock. [Carta]
- Role of nitric oxide production in anaphylaxis and its relevance for the treatment of anaphylactic hypotension with methylene blue
- The 2010 ESC/EACTS guidelines on myocardial revascularization does not present suggestions about disease-free saphenous vein grafts at the time of redo coronary artery bypass grafting. [Carta]
- Vasoplegic syndrome after off-pump coronary artery bypass surgery.[Carta]: a rising threat
- Initial interrater reliability for a novel measure of patient mobility in a cardiovascular intensive care unit
- In vitro reactivity ("organ chamber") of guinea pig tracheal rings: methodology considerations
- Considerations about the bibliometric impact factor [Editorial]: the BJCVS is on the right track
- New achievements, recognition and a farewell. [Editorial]
- Broad spectrum vasopressors support sparing strategies in vasodilatory shock beyond the vascular receptors [Carta]
- Reasons to keep “case reports” alive [Editorial]
Informações sobre o DOI: 10.1186/s13054-018-2024-y (Fonte: oaDOI API)
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas